ICD-10-CM Billable Code

K59.81

Ogilvie syndrome

Clinical Classification Guidelines

Inclusion Terms

  • Acute colonic pseudo-obstruction (ACPO)

Medical Intelligence & Overview

Ogilvie syndrome, also known as acute colonic pseudo-obstruction (ACPO), is a condition characterized by severe dilation of the colon without any physical blockage. It mimics a serious medical emergency similar to a bowel obstruction, but no actual physical obstruction is present. Understanding this condition can help patients recognize symptoms early and seek appropriate medical care.

Causes & Symptoms

Clinical Causes: Major surgery, especially abdominal or pelvic operations Severe infections or sepsis Trauma or injury to the abdomen Electrolyte imbalances, such as low potassium or magnesium levels Certain medications, particularly those affecting nerve signals to the colon like opioids or anticholinergics Neurological disorders including Parkinson’s disease or multiple sclerosis Respiratory failure requiring mechanical ventilation Underlying illnesses such as cardiac failure, systemic inflammatory conditions, or metabolic disturbances

Key Symptoms: Abdominal distension or bloating Inability to pass stool or gas Diffuse abdominal pain or discomfort Nausea and vomiting Slow or absent bowel sounds General feeling of weakness or malaise Fever may occasionally occur if infection develops

Diagnostic & Treatment

Diagnosis Path: Diagnosis involves a combination of clinical assessment, physical examination, and imaging tests. Key diagnostic steps include: - Physical exam revealing a distended abdomen - Imaging studies like abdominal X-rays showing colonic dilation - CT scans may help rule out a physical obstruction - Blood tests to check for electrolyte imbalances and signs of infection Understanding that no mechanical blockage is involved is crucial; this distinction often requires detailed imaging and medical evaluation.

Treatment Protocols: Management of Ogilvie syndrome focuses on relieving the colonic dilation and addressing its underlying cause. Common treatment approaches include: - Bowel rest by fasting to decrease colon activity - Nasogastric tube insertion to decompress the stomach - Correcting electrolyte imbalances with intravenous fluids and supplements - Discontinuing medications that may impair bowel motility - Pharmacologic therapy with medications like neostigmine, which stimulates colonic motility (under medical supervision) - Endoscopic decompression if the colon remains distended and symptoms persist - Surgery is generally reserved for cases where nonsurgical methods fail or complications such as perforation occur It is critical for patients to follow medical advice and notify healthcare providers of worsening symptoms or signs of perforation, such as severe abdominal pain and rapid deterioration.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is K59.81 a billable ICD-10 code?
Yes, K59.81 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report K59.81?
Clinical documentation must specify the nature of Ogilvie syndrome and any associated comorbidities for accurate reporting.

Cite this Clinical Reference

Clinical Meta Tags

ogilvie syndrome